NEW YORK, NY. September 30, 2021. The Lupus Research Alliance (LRA) is pleased to invite the global community to join together as one at its virtual ManyOne Can. Walk with Us to Cure Lupus celebratory event. The aim is to unite and inspire the entire world on one day, Saturday, October 2, 2021, to achieve one […] READ MORE
September 22, 2021 Should people with lupus be vaccinated against COVID-19? Should people with lupus take the third dose of the Pfizer/Biogen or Moderna mRNA COVID-19 vaccine? Do people with lupus qualify as immunocompromised? How can people with lupus protect themselves from COVID-19? Many of you have had these questions and more since the U.S. […] READ MORE
This Largest-Ever Grant Will Fund Two Projects Examining Why Lupus Differs for Each Person NEW YORK, NY. Sept. 21. Today, the Lupus Research Alliance is pleased to announce the inaugural recipients of its largest grant to date, the Global Team Science Award, which will fund international, multidisciplinary research teams to unravel lupus heterogeneity with the […] READ MORE
September 15, 2021 Four-time NYC Marathoner Amy Cargain is taking on the challenge once again this year because every mile helps raise awareness for lupus and lupus research. And for Amy, the Lupus Research Alliance was her number one charity to run for. “The LRA is home to me, and the staff is like family. […] READ MORE
September 2, 2021 The United Nations designated September 5 as the annual International Day of Charity to urge people worldwide to help others through volunteer and philanthropic activities. The Lupus Research Alliance is happy to join groups around the world in acknowledging this important yearly observance. We are very proud to be recognized by several independent charity watchdog organizations that monitor and encourage […] READ MORE
August 24, 2021 We give a big thank you to the Lupus and Allied Diseases Association, Inc. (LADA) for their generous donation of $120,000 to support research funded by the Lupus Research Alliance. The funding is specifically directed to Dr. Zahi Touma at University of Toronto for his Modeling Cognitive Impairment project and Dr. Joyce Chang at Boston Children’s […] READ MORE
August 18, 2021 Many lupus patients are at risk for COVID-19 infection because of treatment with corticosteroids and other immunosuppressive medications and will be eligible for booster vaccination. However, there are large gaps in our understanding of who will benefit from the booster vaccines, what strategies will improve response to the vaccine and the best […] READ MORE
August 13, 2021 – 4:45 PM The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices voted unanimously to recommend, and CDC Director Rochelle Walensky, MD subsequently approved, that people with moderately to severely weakened immune systems receive a third dose of the COVID-19 Pfizer or Moderna vaccines. The CDC defined the […] READ MORE
August 13, 2021 As you have probably heard on the news, the U.S. Food and Drug Administration granted late last night Emergency Use Authorization of a booster third dose of the Pfizer and Moderna COVID-19 vaccine for “some people who are immunocompromised — specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered […] READ MORE
August 12, 2021 In two recent studies, researchers found that the four COVID-19 vaccines are well-tolerated in lupus patients. Given that the Moderna and Pfizer vaccines are the first mRNA vaccines currently authorized for the emergency use in people, lupus researchers have since worked to answer questions specifically about potential side effects and whether these […] READ MORE
Research Funded by the Lupus Research Alliance Published in Today’s “Cell” NEW YORK, NY August 11. Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in New York identified problems in the red blood cells of children with active Systemic Lupus Erythematosus […] READ MORE
August 2, 2021 Dear Friend of the Lupus Research Alliance, As we reported this morning, the lupus community has much to celebrate with the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (brand name, Saphnelo™). As a first-in-class and only new treatment for systemic lupus erythematosus in a decade, this approval marks a major […] READ MORE
